Member Info for Okehurst1

Hi TW,
I think Regulator is correct - as below - regarding MHRA Home use, if you find disclosure that Biosure have secured private purchase home use please share
With respect I know you produce some decent research I can’t source.

Just on the technical side of the Biotech antibody test, you could be correct, I am just going off the Abingdon RNS this morning

‘Our own AbC-19 assay will complement this product and we expect the AbC-19 to gain additional utility in semi-quantitative format as recently announced. BioSure also distributes our AbC-19 test which is CE marked for professional use’

No idea if this good or bad news for the AbC -19
Test

Abingdon up 54% on their news today - good luck to their shareholders

Market realising Omega next

Having the Logo means nothing, companies still need MHRA to clear CE accreditation

Interesting, can’t see MHRA approval anywhere?
I emailed Biosure earlier to ask them the same but no response as yet.

Agree I couldn’t see Abingdon doing this but then again why not say within the marketing blurb that they had secured the coveted MHRA House Use status ?
They would be the only one in the U.K. - paid for not given away by the Government

TW, some good points.

Unless I am missing something this is still only a CE accreditation?

‘This new test, for which BioSure is the legal manufacturer, has been CE marked specifically for self-testing’

Yes they want Home Use but not cleared by MHRA

Same with the biotech they are using;

‘Our own AbC-19 assay will complement this product and we expect the AbC-19 to gain additional utility in semi-quantitative format as recently announced. BioSure also distributes our AbC-19 test which is CE marked for professional use’

Appreciate it’s ambiguous but it looks like a rebadged
AbC -19 test to me ?

Interesting that they are using the Abc -19 biotech to compliment this test

Chris Yates, CEO of Abingdon Health, commented: "We are delighted that BioSure have launched their product and equally happy to be their manufacturing partner. For individuals to be able to monitor their own antibody status at home is a great step in the management of COVID-19. Our own AbC-19 assay will complement this product and we expect the AbC-19 to gain additional utility in semi-quantitative format as recently announced. BioSure also distributes our AbC-19 test which is CE marked for professional use.

https://www.forbes.com/sites/williamhaseltine/2021/08/10/it-is-time-to-pay-close-attention-to-the-lambda-variant-now-devastating-south-america/

We are all here to make a few £quid
Be it we are bullish and want the share price to rise or we are gaming the BB to drive the price down , either way we are all in the big life boat together on this one.

If this is it for jabs then we only have our natural immune system and it doesn’t look like any more vaccines once you have had 2 - unless extremely vulnerable - and their effectiveness starts expire after 6 months and is possibly gone by 270 days
Scary stuff

https://www.thetimes.co.uk/article/covid-booster-jabs-why-you-probably-wont-get-one-this-autumn-fkmm9dzgn

Looks like it’s all over for the booster Jabs in the U.K. and around the world

In affect the vaccine wears off after 6 months and to continually keeping using boosters allows the variants to develop - as we well know that is within the base of the S protein spike - as they evade the vaccine

May be wrong but antibody testing won’t get us out of this mess - to stop another lockdown - it will be Antigen tests but there is not enough specialist engineers to manufacture the LFT’s

Omega is now arguably the largest in Europe

It’s worrying developments that we won’t be getting that 3rd jab and possibly this is all they will give the public, even on the LFT front Omega couldn’t even touch the surface of how many LFT’s are going to be required

We can start to see now why the DHSC sent Toyota into Omega to set up the £17M of kit they have supplied and they sent even more kit a few weeks ago.

Captain, fully agree antibody priced in

All about the 100M a year Antigen LFT’s now and £400M of annual revenue , been a long time coming and very frustrating it’s been but we are almost there, everything in place.

You have come this far to sell out now, hold your nerve, the share price will go north very shortly as the positive news flows in.

Good luck

Can’t see a fall of note Big Hero, too much data coming through, we have support at these levels, holders know news is inbound, U.K, USA, EU it’s coming and Covid unfortunately is going nowhere.

Agree it’s frustrating but not long, DHSC take over processes 1st Sept, these guys ain’t spent money on Toyota Engineers helping Omega, ditto investing £17M in kit including a top up just after GAD was bought out by Soros/Gates.

250no they say ....

https://twitter.com/omegadiagnostic/status/1389963952793309184?s=10

Revenue assessment via Shredz contact.

https://twitter.com/shredz90/status/1429503772502470657?s=10

The data is lining up, issue will be we are restricted to
100M a year capacity, it is decent case wise as it’s £400M p/a

Interesting to see news agencies across the USA report there are shortages of LFT’s - especially after the Chinese biotech from Innova was banned in the USA for being useless.

Omega sitting in such a good position, USA validation any time soon, put aside EU/ U.K.
Problem will be we are restricted by capacity of 100M a year

Think about that revenue number , could be £400M p/a

The m/cap won’t be £85M once the orders flow

Do your own research and ask the question why would so called investors in Omega only post negative comments?

If you have come this far a few more weeks and the sales orders will be in the bag alongside the £374M contract.

As I say do your own research but it’s coming together for Omega

https://twitter.com/tom_the_bomb__/status/1429486378556006405?s=10

https://www.gov.uk/government/publications/antibody-testing-for-sars-cov-2-information-for-general-practitioners/antibody-testing-for-sars-cov-2-information-for-general-practitioners

Lord Bethall tweeting away

https://twitter.com/jimbethell/status/1425379571671654402?s=10

The narrative is changing ... test test test and stimulate the natural immune system

The narrative is shifting, we had Astra Zeneca come out on Friday saying;

https://www.cnbc.com/2021/08/20/astrazenecas-antibody-therapy-prevents-covid-study-shows.html

Then Austria today;

https://www.independent.co.uk/travel/news-and-advice/austria-travel-covid-vaccine-expiry-b1904529.html

BBC today ;

https://www.bbc.com/news/health-58270098

Looks like the Scientists are saying we can’t use booster vaccines forever to get out of this mess - vaccine protection is less than 270 days - as it allows the virus variants to form unless the whole world was vaccinated same time( in affect)

It appears the shift will be to try and protect the very vulnerable and move the population to increasing their antibodies but not with a vaccine as such.

Antigen testing will be with us for years as will antibody testing, it makes little odds to Omega who as specialist diagnostics engineers can manufacture either and are well set up to take advantage.

How long they stay independent will be the next big question once the contracts roll in this autumn, one of Europe’s biggest and technically best engineers will be a target to be acquired.

Blu, could be wrong but can’t see the antibody test for this trial having anything to do with Omega, all about Antigen for us now.

With Abingdon in dispute with the Government over non payment for Antibody tests it’s doubtful it’s the ABC -19 test?

Omega enjoyed 75p gross margin providing cassettes for the above test, we know we are manufacturing cassettes for the Government direct today but we don’t know the terms / volume/ gross margin.?

As Big Hero says does the Government pay for boosters for everyone every 26 weeks - Pfizer $22 a shot at least - or measure the effectiveness of the vaccine via antibodies?

Looks like Austria already made its mind up on how low long the current vaccine lasts.... 38 weeks

https://www.independent.co.uk/travel/news-and-advice/austria-travel-covid-vaccine-expiry-b1904529.html

Think any investor takes a view based on their research

Covid not going away, £17M of DHSC kit, 250no staff ,
27,000sq/ft manufacturing plant , £6M cash at hand, based on independent/ external validation the Mologic antigen biotech out performs any of the Chinese tests up to Ct27 and viral load up to 7.00E
Northern Ireland validation underway,
EU CE accreditation sorted , the same biotech is on a USA FDA funded platform and Omega now awaiting USA clearance ditto home use clearance for EU & 27no countries also submitted and hopefully post Northern Island trials next week and we should secure U.K. home use due to the same and in association DHSC taking control of validation of antigen tests.
Plus we have £374M contract in the back pocket that will go live shortly, plus in my opinion we may enjoy some of the GAD capacity £900M contract as Gates/ Soros will focus on 3rd world countries.

Agree Omega were a tin pot business 17 months ago but due to the £17M of kit , rights issue and engineering capacity that has been expanded on the back of both and coupled with many years experience as a specialist engineer they are arguably now one of the largest and best LFT manufacturer in Europe with potential capacity to 100M plus LFT’s per annum.

We could also throw in the only WHO approved HIV test and the only Life Sciences Co with Home Use approval Food Tolerance LFT in China ,I have discounted these last 2 to Zero value in my calculation, ditto Omega currently manufacturing cassettes for the Government, ditto the Antibody test.

I do agree the PR/ ramping then directors selling is extremely frustrating but Colin never sold personally in fact he bought in the market @ 55p and to be fair to the man he has set the business up in a good position in the last 15 months

If an investor thinks none of the above will come then of course best sell, if you think it will come to fruition then hold, that’s where we are today, we are very very close.